Vaccines help the body fight disease and therefore immunization is a key component of primary health care and is a development success story that saves millions of lives every year. They work to protect the body from viruses (e.g., human papillomavirus, hepatitis B virus) or boost the body's immune system to fight cancer.

August is National Immunization Awareness Month, and we would like to share some of the high-quality and innovative research findings published in Cancers (ISSN: 2072-6694).

The list of relevant papers can be seen below:

“Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines”
by Tomić, S.; Petrović, A.; Puač, N.; Škoro, N.; Bekić, M.; Petrović, Z. L.; Čolić, M.
Cancers 2021, 13(7), 1626; https://doi.org/10.3390/cancers13071626
Available online: https://www.mdpi.com/2072-6694/13/7/1626

“COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience”
by So, A. C. P.; McGrath, H.; Ting, J.; Srikandarajah, K.; Germanou, S.; Moss, C.; Russell, B.; Monroy-Iglesias, M.; Dolly, S.; Irshad, S.; Van Hemelrijck, M.; Enting, D.
Cancers 2021, 13(14), 3573; https://doi.org/10.3390/cancers13143573
Available online: https://www.mdpi.com/2072-6694/13/14/3573

“Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs”
by Agbarya, A.; Sarel, I.; Ziv-Baran, T.; Agranat, S.; Schwartz, O.; Shai, A.; Nordheimer, S.; Fenig, S.; Shechtman, Y.; Kozlener, E.; Taha, T.; Nasrallah, H.; Parikh, R.; Elkoshi, N.; Levy, C.; Khoury, R.; Brenner, R.
Cancers 2021, 13(16), 4191; https://doi.org/10.3390/cancers13164191
Available online: https://www.mdpi.com/2072-6694/13/16/4191

“Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy”
by Horn, L. A.; Fousek, K.; Hamilton, D. H.; Hodge, J. W.; Zebala, J. A.; Maeda, D. Y.; Schlom, J.; Palena, C.
Cancers 2021, 13(5), 968; https://doi.org/10.3390/cancers13050968
Available online: https://www.mdpi.com/2072-6694/13/5/968

“Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment”
by Ghandili, S.; Schönlein, M.; Lütgehetmann, M.; Schulze zur Wiesch, J.; Becher, H.; Bokemeyer, C.; Sinn, M.; Weisel, K. C.; Leypoldt, L. B.
Cancers 2021, 13(15), 3800; https://doi.org/10.3390/cancers13153800
Available online: https://www.mdpi.com/2072-6694/13/15/3800

“Antigenic Essence: Upgrade of Cellular Cancer Vaccines”
by Lokhov, P. G.; Balashova, E. E.
Cancers 2021, 13(4), 774; https://doi.org/10.3390/cancers13040774
Available online: https://www.mdpi.com/2072-6694/13/4/774

“Vaccine-Based Immunotherapy for Head and Neck Cancers”
by Beyaert, S.; Machiels, J. -P.; Schmitz, S.
Cancers 2021, 13(23), 6041; https://doi.org/10.3390/cancers13236041
Available online: https://www.mdpi.com/2072-6694/13/23/6041

“Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization”
by Przybyla, A.; Lehmann, A. A.; Zhang, T.; Mackiewicz, J.; Galus, Ł.; Kirchenbaum, G. A.; Mackiewicz, A.; Lehmann, P. V.
Cancers 2021, 13(2), 223; https://doi.org/10.3390/cancers13020223
Available online: https://www.mdpi.com/2072-6694/13/2/223

“Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study”
by Jørgensen, N. G.; Kaae, J.; Grauslund, J. H.; Met, Ö.; Nielsen, S. L.; Pedersen, A. W.; Svane, I. M.; Ehrnrooth, E.; Andersen, M. H.; Zachariae, C.; Skov, L.
Cancers 2021, 13(4), 911; https://doi.org/10.3390/cancers13040911
Available online: https://www.mdpi.com/2072-6694/13/4/911

“Novel Protein-Based Vaccine against Self-Antigen Reduces the Formation of Sporadic Colon Adenomas in Mice”
by Belnoue, E.; Leystra, A. A.; Carboni, S.; Cooper, H. S.; Macedo, R. T.; Harvey, K. N.; Colby, K. B.; Campbell, K. S.; Vanderveer, L. A.; Clapper, M. L.; Derouazi, M.
Cancers 2021, 13(4), 845; https://doi.org/10.3390/cancers13040845
Available online: https://www.mdpi.com/2072-6694/13/4/845

You are welcome to submit relevant papers to the journal Section “Cancer Immunology and Immunotherapy” at https://www.mdpi.com/journal/cancers/sections/Cancer_Immunology_Immunotherapy.

Dr. Subbaya Subramanian
Associate Section Editor-in-Chief of Cancers